Annovis Bio, Inc.: corrects audit fees in proxy

What happened Annovis Bio, Inc. filed a Current Report on Form 8-K on Oct 20, 2026 to correct a typographical error in the company’s proxy statement for its annual meeting of stockholders held on Jun 17, 2026. The filing states it is correcting the disclosure of audit fees paid to Ernst & Young LLP.

Key details

• Corrected fee disclosure for Ernst & Young LLP: audit fees for 2025 are $415,000 and for 2024 are $375,000.
• Audit-related fees are $100,000 for 2025 and $107,045 for 2024.
• Tax fees: -- for 2025 and -- for 2024. All other fees: -- for 2025 and -- for 2024.
• Total fees disclosed are $515,000 for 2025 and $482,045 for 2024.

Why it may matter The filing was made under Item 8.01 (other events) to correct the proxy disclosure regarding fees paid to the independent registered public accounting firm; the report also includes Item 9.01 (financial statements and exhibits). This filing does not show why the insider traded or why the company acted.